We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current INCY market cap is 13.89B. The company's latest EPS is USD 0.1685 and P/E is 422.14.
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 1.01B | 881.91M | 1.04B | 1.14B | 1.18B |
| Operating Income | 217.33M | 91.44M | -477.67M | 146.09M | 321.32M |
| Net Income | 201.08M | 169.55M | -444.6M | 106.46M | 201.21M |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 2.67B | 2.99B | 3.39B | 3.7B | 4.24B |
| Operating Income | -263.68M | 585.78M | 579.44M | 649.73M | 81.17M |
| Net Income | -295.7M | 948.58M | 340.66M | 597.6M | 32.62M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 6.78B | 7.14B | 4.66B | 5.01B | 5.44B |
| Total Liabilities | 1.59B | 1.74B | 1.66B | 1.84B | 2B |
| Total Equity | 5.19B | 5.39B | 3B | 3.17B | 3.45B |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 3.56B | 4.93B | 5.84B | 6.78B | 5.44B |
| Total Liabilities | 949.65M | 1.16B | 1.47B | 1.59B | 2B |
| Total Equity | 2.61B | 3.77B | 4.37B | 5.19B | 3.45B |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 496.49M | 218.81M | -356.75M | -45.88M | 335.34M |
| Investing | -207.68M | -73.11M | 140.71M | 178.98M | 157.52M |
| Financing | -20.03M | -12.41M | -2.01B | -2.04B | -2.02B |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -124.6M | 749.49M | 969.94M | 496.49M | 335.34M |
| Investing | -269M | -207.7M | -78.54M | -207.68M | 157.52M |
| Financing | 71.71M | 6.18M | -794k | -20.03M | -2.02B |
| Market Cap | 13.89B |
| Price to Earnings Ratio | 422.14 |
| Price to Sales Ratio | 3.24 |
| Price to Cash Ratio | 8.16 |
| Price to Book Ratio | 3.99 |
| Dividend Yield | - |
| Shares Outstanding | 193.52M |
| Average Volume (1 week) | 1.6M |
| Average Volume (1 Month) | 1.78M |
| 52 Week Change | 19.30% |
| 52 Week High | 83.95 |
| 52 Week Low | 50.3498 |
| Spread (Intraday) | 1.09 (1.52%) |
| Company Name | Incyte Corporation |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.incyte.com |
| Industry | coml physical, biologcl resh (8731) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
